|
Showing the most relevant articles for your search:NYSE:WPI | 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | | 2013/01/30 | 01 : 24 | Zacks | MedTech Industry Stock Outlook - Jan 2013 - Industry Outlook | NYSE:WPI | Actavis, Inc. |
| 2013/01/24 | 23 : 00 | PR Newswire (US) | Watson Pharmaceuticals, Inc. is Now Actavis, Inc. | NYSE:WPI | Actavis, Inc. |
| 2013/01/23 | 23 : 29 | PR Newswire (US) | Watson Confirms Opana® ER Patent Challenge | NYSE:WPI | Actavis, Inc. |
| 2013/01/23 | 21 : 30 | PR Newswire (US) | Watson Acquires Uteron Pharma SA | NYSE:WPI | Actavis, Inc. |
| 2013/01/23 | 01 : 30 | Zacks | Canada Approves Forest's Bystolic - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/18 | 22 : 00 | PR Newswire (US) | Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy | NYSE:WPI | Actavis, Inc. |
| 2013/01/18 | 22 : 00 | PR Newswire (US) | Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy | NYSE:WPI | Actavis, Inc. |
| 2013/01/15 | 08 : 41 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NYSE:WPI | Actavis, Inc. |
| 2013/01/15 | 08 : 41 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NYSE:WPI | Actavis, Inc. |
| 2013/01/11 | 23 : 15 | PR Newswire (US) | Watson To Host 2013 Investor Meeting January 25 In New York | NYSE:WPI | Actavis, Inc. |
| 2013/01/10 | 02 : 00 | Zacks | Forest Settles with Glenmark - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/09 | 06 : 32 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:WPI | Actavis, Inc. |
| 2013/01/09 | 06 : 32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:WPI | Actavis, Inc. |
| 2013/01/08 | 18 : 36 | Zacks | Stock Market News for January 8, 2013 - Market News | NYSE:WPI | Actavis, Inc. |
| 2013/01/07 | 23 : 52 | Zacks | Impax Launches Opana ER Generic - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/07 | 20 : 00 | Zacks | Watson's Generic Product Approved - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/05 | 03 : 21 | Zacks | Tough Times Ahead for Endo Health - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/05 | 03 : 17 | Zacks | Patent Challenge for Auxilium Pharma - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2013/01/03 | 23 : 00 | PR Newswire (US) | Watson's Generic Lysteda® Receives FDA Approval | NYSE:WPI | Actavis, Inc. |
| 2013/01/02 | 19 : 00 | Zacks | Watson Files Velcade ANDA - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2012/12/28 | 23 : 00 | PR Newswire (US) | Watson Confirms Velcade® Patent Challenge | NYSE:WPI | Actavis, Inc. |
| 2012/12/28 | 22 : 33 | PR Newswire (US) | EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals | NYSE:WPI | Actavis, Inc. |
| 2012/12/28 | 22 : 33 | PR Newswire (US) | EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals | NYSE:WPI | Actavis, Inc. |
| 2012/12/26 | 23 : 28 | Marketwired | LYB, WPI, SSYS and HW Freshly Hit a New 52-Week High | NYSE:WPI | Actavis, Inc. |
| 2012/12/21 | 23 : 15 | PR Newswire (US) | Watson to Present at the 31st Annual J.P. Morgan Healthcare Conference | NYSE:WPI | Actavis, Inc. |
| 2012/12/20 | 23 : 15 | PR Newswire (US) | Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top | NYSE:WPI | Actavis, Inc. |
| 2012/12/14 | 22 : 14 | Zacks | An End to Drug Patent Woes? - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2012/12/14 | 17 : 20 | Zacks | Endo Cuts EPS View, CEO to Retire - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 2012/12/06 | 22 : 34 | Zacks | Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook | NYSE:WPI | Actavis, Inc. |
| 2012/12/06 | 09 : 00 | Zacks | Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook | NYSE:WPI | Actavis, Inc. |
|
Showing the most relevant articles for your search:NYSE:WPI |
|